N.v. Nutricia

Jan Maarten Verkuijl

Robert Johan Joseph Hageman

Mattheus Cornelis De Wilde

Ladislaus Maria Broersen

Sofia Lopes Da Silva

Danielle Stefanie Counotte

Paul Johannes Maria Savelkoul

Myryam Rakhshandehroo

The invention pertains to the use of therapeutically effective amounts of (i) vitamin A and/or functional equivalents, (ii) vitamin D and/or functional equivalents, and (iii) at least one omega-3 PUFA, preferably DHA and/or EPA, more preferably DHA and EPA, for the manufacture of a composition or medicament for treating, reducing and/or preventing neuroinflammation and/or symptoms associated with neuroinflammation in a subject in need thereof, as well as for reducing microglia activation, and/or for treating, reducing and/or preventing symptoms associated with excessive activation of microglia; and/or for reducing the secretion of inflammatory cytokines, preferably IL-6, and/or for treating, reducing and/or preventing symptoms associated with excessive secretion of inflammatory cytokines, in a subject in need thereof.

Method for controlling neuroinflammation

Growing community of inventors

Utrecht, Netherlands

Jan Maarten Verkuijl